(Q77809625)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893773%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Low-dose formoterol Turbuhaler (Oxis) b.i.d., a 3-month placebo-controlled comparison with terbutaline (q.i.d.). (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893773%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

1 reference

T Ekström

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893773%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

N Ringdal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893773%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

V Sobradillo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893773%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

E Runnerström

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893773%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

S Soliman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893773%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893773%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893773%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893773%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893773%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

1040-1045

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893773%20AND%20SRC:MED&resulttype=core&format=json

Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990352-3

7 January 2021

Multicenter 1-year trial on formoterol, a new long-acting beta 2-agonist, in chronic obstructive airway disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990352-3

7 January 2021

A dose-response study with formoterol Turbuhaler as maintenance therapy in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990352-3

7 January 2021

Efficacy and tolerance of a 12-week treatment with inhaled formoterol in patients with reversible obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990352-3

7 January 2021

Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990352-3

7 January 2021

Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990352-3

7 January 2021

Are there any detrimental effects of the use of inhaled long-acting beta 2-agonists in the treatment of asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990352-3

7 January 2021

Regular inhaled beta-agonist treatment in bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990352-3

7 January 2021

Functional antagonism: tolerance produced by inhaled beta 2 agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990352-3

7 January 2021

The inhalation device influences lung deposition and bronchodilating effect of terbutaline

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990352-3

7 January 2021

10.1016/S0954-6111(98)90352-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893773%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference